TUSTIN, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), a biopharmaceutical company developing targeted therapeutics for the treatment of cancer and hepatitis C virus (HCV) infection, today announced that senior management will present at the C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30, 2006 at 4:30 pm EST. The presentation will be held at The Palace Hotel in New York City.
